Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1194396-71-8
2. Ncx 470
3. Bimatoprost Grenod
4. [(e,3s)-1-[(1r,2r,3s,5r)-2-[(z)-7-(ethylamino)-7-oxohept-2-enyl]-3,5-dihydroxycyclopentyl]-5-phenylpent-1-en-3-yl] 6-nitrooxyhexanoate
5. Bimatoprost Grenod (usan)
6. Bimatoprost Grenod [usan]
7. Bimatoprost Grenod [inn]
8. Qp51be89ne
9. Schembl397725
10. C31h46n2o8
11. Akos040755517
12. Da-56065
13. Ms-30350
14. Hy-139419
15. Cs-0200448
16. D12599
17. 15-(6-nitroxyhexanoyl)-17-phenyl Trinor Prostaglandin F2??
18. (s,e)-1-((1r,2r,3s,5r)-2-((z)-7-(ethylamino)-7-oxohept-2-en-1-yl)-3,5-dihydroxycyclopentyl)-5-phenylpent-1-en-3-yl 6-(nitrooxy)hexanoate
19. [(e,1s)-3-[(1r,2r,3s,5r)-2-[(z)-7-(ethylamino)-7-oxo-hept-2-enyl]-3,5-dihydroxy-cyclopentyl]-1-(2-phenylethyl)allyl] 6-nitrooxyhexanoate
20. Hexanoic Acid, 6-(nitrooxy)-, (1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl Ester
| Molecular Weight | 574.7 g/mol |
|---|---|
| Molecular Formula | C31H46N2O8 |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 20 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 151 |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 821 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
78
PharmaCompass offers a list of Bimatoprost Grenod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bimatoprost Grenod manufacturer or Bimatoprost Grenod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bimatoprost Grenod manufacturer or Bimatoprost Grenod supplier.
A Bimatoprost Grenod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bimatoprost Grenod, including repackagers and relabelers. The FDA regulates Bimatoprost Grenod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bimatoprost Grenod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bimatoprost Grenod manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Bimatoprost Grenod supplier is an individual or a company that provides Bimatoprost Grenod active pharmaceutical ingredient (API) or Bimatoprost Grenod finished formulations upon request. The Bimatoprost Grenod suppliers may include Bimatoprost Grenod API manufacturers, exporters, distributors and traders.
click here to find a list of Bimatoprost Grenod suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Bimatoprost Grenod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bimatoprost Grenod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bimatoprost Grenod GMP manufacturer or Bimatoprost Grenod GMP API supplier for your needs.
A Bimatoprost Grenod CoA (Certificate of Analysis) is a formal document that attests to Bimatoprost Grenod's compliance with Bimatoprost Grenod specifications and serves as a tool for batch-level quality control.
Bimatoprost Grenod CoA mostly includes findings from lab analyses of a specific batch. For each Bimatoprost Grenod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bimatoprost Grenod may be tested according to a variety of international standards, such as European Pharmacopoeia (Bimatoprost Grenod EP), Bimatoprost Grenod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bimatoprost Grenod USP).
